Results 51 to 60 of about 74,305 (343)
The epidemiology of alopecia areata: a population‐based cohort study in UK primary care
British Journal of Dermatology, 2021 There is a lack of population‐based information on the disease burden and management of alopecia areata (AA).
M. Harries +8 more
semanticscholar +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Alopecia Areata: An Autoimmune Disease of Multiple Players
ImmunoTargets and Therapy, 2021 Alopecia areata (AA) is an autoimmune disease of the hair follicles. It is characterized by a well-defined non-scarring alopecic patch or patches that may extend to the entire scalp or lead to total body hair loss.
Poonkiat Suchonwanit +2 more
semanticscholar +1 more source
The role of extracellular vesicles in cutaneous remodeling and hair follicle dynamics [PDF]
, 2019 Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are cell-derived membranous structures that were originally catalogued as a way of releasing cellular waste products.
Carrasco, Elisa +2 more
core +2 more sources
A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
Clinical, Cosmetic and Investigational Dermatology, 2021 Alopecia areata (AA) is a chronic, immune-mediated form of nonscarring alopecia that is multifactorial and results in localized patches. It is often described as a self-limiting condition that results in the spontaneous regrowth of hair in most cases ...
Kerry A. Dillon
semanticscholar +1 more source
Acta Dermato-Venereologica, 2018 The development of androgenetic alopecia is associated with a risk of developing cardiovascular diseases, but the association of alopecia areata with cardiovascular diseases in humans is largely unexplored.
Eddy Hsi Wang +7 more
doaj +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several
Jundong Huang +5 more
doaj +1 more source
Post-Partum Pituitary Insufficiency and Livedo Reticularis Presenting a Diagnostic Challenge in a Resource Limited Setting in Tanzania: A Case Report, Clinical Discussion and Brief Review of Existing Literature. [PDF]
, 2012 Pituitary disorders following pregnancy are an important yet under reported clinical entity in the developing world. Conversely, post partum panhypopituitarism has a more devastating impact on women in such settings due to high fertility rates, poor ...
A Cénac +27 more
core +3 more sources
Alopecia areata after ChAdOx1 nCoV‐19 vaccine (Oxford/AstraZeneca): a potential triggering factor?
Journal of Cosmetic Dermatology, 2021 Dear Editor, Many dermatologists have been occupied with recording cutaneous associations with SARSCoV2 infection, and there are some reports about cutaneous side effects of its vaccines.1 Only a few reports described a possible association between AA ...
Reham Essam +4 more
semanticscholar +1 more source
Allergology International, 2020 Background: The Japanese guidelines for the treatment of alopecia areata list topical immunotherapies as a drug therapy for this condition. However, there is insufficient evidence of its efficacy to support this recommendation. Thus, we sought to clarify
Keisuke Sakai +6 more
doaj +1 more source